Frequently Asked Questions
The market is segmented based on , By Causative Agent (Mycoplasma, Bacteria, Virus and Others), Treatment Type (Vaccines and Drugs), Route of Administration (Parenteral and Oral), Distribution Channel (Pharmacies, Veterinary Clinics, Veterinary Hospitals and Others) - Industry Trends and Forecast to 2030.
.
The Global Swine Respiratory Diseases Treatment Market size was valued at USD 2104.00 USD Million in 2022.
The Global Swine Respiratory Diseases Treatment Market is projected to grow at a CAGR of 6.3% during the forecast period of 2023 to 2030.
The major players operating in the market include Boehringer Ingelheim Vetmedica , Norbrook, Ceva Santé Animale, Zoetis , Agrilabs , Thermo Fisher Scientific , Vetoquinol, Bimeda Holdings PLC, Bayer AG, Elanco Animal Health, Virbac Group, Merck Animal Health, Phibro Animal Health Corporation, HESTER BIOSCIENCES LIMITED, Neogen Corporation, Vaxxinova, IDT Biologika, Dechra Pharmaceuticals PLC, Biogénesis Bagó, Phytobiotics Futterzusatzstoffe GmbH.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of the Middle East and Africa.
